Lazard Capital Downgrades Abiomed (ABMD) to Hold

November 9, 2009 11:13 AM EST

Lazard Capital downgrades Abiomed (Nasdaq: ABMD) from Buy to Hold.

To see more analyst ratings on ABMD Click Here.

Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients.


Related Categories

Downgrades

Stocks Mentioned

ABMD 8.14

-0.41 -4.80%
Volume: 220,960
Track ABMD


Related Entities


Add Your Comment